APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rabies Immune Globulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rabies Immune Globulin Industry Growth and Trends Forecast to 2032

2 January 2026101 pages

Choose your research edition.

Industry ResearchRabies Immune Globulin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Immune Globulin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Rabies Immune Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Immune Globulin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Immune Globulin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rabies Immune Globulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rabies Immune Globulin include Sichuan Yuanda Shuyang, Weiguang Bio, Shanghai RAAS, Sanofi, Shuanglin Bio, VINS, Kamada, Grifols and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rabies Immune Globulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rabies Immune Globulin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rabies Immune Globulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rabies Immune Globulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rabies Immune Globulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rabies Immune Globulin Market by Company

Sichuan Yuanda Shuyang

Weiguang Bio

Shanghai RAAS

Sanofi

Shuanglin Bio

VINS

Kamada

Grifols

CSL Behring

CNBG

CBPO

Bharat Serum

Rabies Immune Globulin Segment by Type

ERIG

HRIG

Rabies Immune Globulin Segment by Application

Category II Exposure

Category III Exposure

Rabies Immune Globulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Immune Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rabies Immune Globulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rabies Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ERIG Table 2. Major Company of HRIG Table 3. Global Rabies Immune Globulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 5. Global Rabies Immune Globulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rabies Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rabies Immune Globulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Rabies Immune Globulin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Rabies Immune Globulin Sales by Type (2027-2032) & (K Units) Table 10. Global Rabies Immune Globulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rabies Immune Globulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rabies Immune Globulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Rabies Immune Globulin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 15. North America Rabies Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 17. Europe Rabies Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Rabies Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Rabies Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Rabies Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 24. Rabies Immune Globulin Industry Trends Table 25. Rabies Immune Globulin Industry Drivers Table 26. Rabies Immune Globulin Industry Opportunities and Challenges Table 27. Rabies Immune Globulin Industry Restraints Table 28. Global Rabies Immune Globulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rabies Immune Globulin Revenue Market Share by Company (2021-2026) Table 30. Global Rabies Immune Globulin Sales by Company (2021-2026) & (K Units) Table 31. Global Rabies Immune Globulin Sales Share by Company (2021-2026) Table 32. Global Rabies Immune Globulin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Rabies Immune Globulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rabies Immune Globulin Major Company Production Sites and Headquarters Table 35. Global Rabies Immune Globulin Company, Product Type & Application Table 36. Global Rabies Immune Globulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rabies Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rabies Immune Globulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rabies Immune Globulin Sales by Region (2021-2026) & (K Units) Table 41. Global Rabies Immune Globulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rabies Immune Globulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rabies Immune Globulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Rabies Immune Globulin Sales by Region (2027-2032) & (K Units) Table 46. Global Rabies Immune Globulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rabies Immune Globulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rabies Immune Globulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Rabies Immune Globulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Rabies Immune Globulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 52. Global Rabies Immune Globulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rabies Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rabies Immune Globulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Rabies Immune Globulin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Rabies Immune Globulin Sales by Application (2027-2032) & (K Units) Table 57. Global Rabies Immune Globulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rabies Immune Globulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rabies Immune Globulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Rabies Immune Globulin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 62. North America Rabies Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 64. Europe Rabies Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Rabies Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Rabies Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Rabies Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 71. Sichuan Yuanda Shuyang Company Information Table 72. Sichuan Yuanda Shuyang Business Overview Table 73. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio Table 75. Sichuan Yuanda Shuyang Recent Development Table 76. Weiguang Bio Company Information Table 77. Weiguang Bio Business Overview Table 78. Weiguang Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Weiguang Bio Rabies Immune Globulin Product Portfolio Table 80. Weiguang Bio Recent Development Table 81. Shanghai RAAS Company Information Table 82. Shanghai RAAS Business Overview Table 83. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Shanghai RAAS Rabies Immune Globulin Product Portfolio Table 85. Shanghai RAAS Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sanofi Rabies Immune Globulin Product Portfolio Table 90. Sanofi Recent Development Table 91. Shuanglin Bio Company Information Table 92. Shuanglin Bio Business Overview Table 93. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shuanglin Bio Rabies Immune Globulin Product Portfolio Table 95. Shuanglin Bio Recent Development Table 96. VINS Company Information Table 97. VINS Business Overview Table 98. VINS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. VINS Rabies Immune Globulin Product Portfolio Table 100. VINS Recent Development Table 101. Kamada Company Information Table 102. Kamada Business Overview Table 103. Kamada Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Kamada Rabies Immune Globulin Product Portfolio Table 105. Kamada Recent Development Table 106. Grifols Company Information Table 107. Grifols Business Overview Table 108. Grifols Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Grifols Rabies Immune Globulin Product Portfolio Table 110. Grifols Recent Development Table 111. CSL Behring Company Information Table 112. CSL Behring Business Overview Table 113. CSL Behring Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CSL Behring Rabies Immune Globulin Product Portfolio Table 115. CSL Behring Recent Development Table 116. CNBG Company Information Table 117. CNBG Business Overview Table 118. CNBG Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. CNBG Rabies Immune Globulin Product Portfolio Table 120. CNBG Recent Development Table 121. CBPO Company Information Table 122. CBPO Business Overview Table 123. CBPO Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. CBPO Rabies Immune Globulin Product Portfolio Table 125. CBPO Recent Development Table 126. Bharat Serum Company Information Table 127. Bharat Serum Business Overview Table 128. Bharat Serum Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Bharat Serum Rabies Immune Globulin Product Portfolio Table 130. Bharat Serum Recent Development Table 131. North America Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 133. North America Rabies Immune Globulin Sales Market Share by Country (2021-2026) Table 134. North America Rabies Immune Globulin Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Rabies Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 136. North America Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Rabies Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Rabies Immune Globulin Market Share by Country (2021-2026) Table 139. North America Rabies Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Rabies Immune Globulin Market Share Forecast by Country (2027-2032) Table 141. Europe Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 143. Europe Rabies Immune Globulin Sales Market Share by Country (2021-2026) Table 144. Europe Rabies Immune Globulin Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Rabies Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Rabies Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Rabies Immune Globulin Market Share by Country (2021-2026) Table 149. Europe Rabies Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Rabies Immune Globulin Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Rabies Immune Globulin Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Rabies Immune Globulin Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Rabies Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Rabies Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Rabies Immune Globulin Market Share by Country (2021-2026) Table 159. Asia-Pacific Rabies Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Rabies Immune Globulin Market Share Forecast by Country (2027-2032) Table 161. Latin America Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 163. Latin America Rabies Immune Globulin Sales Market Share by Country (2021-2026) Table 164. Latin America Rabies Immune Globulin Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Rabies Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Rabies Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Rabies Immune Globulin Market Share by Country (2021-2026) Table 169. Latin America Rabies Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Rabies Immune Globulin Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Rabies Immune Globulin Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Rabies Immune Globulin Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Rabies Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Rabies Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Rabies Immune Globulin Market Share by Country (2021-2026) Table 179. Middle East and Africa Rabies Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Rabies Immune Globulin Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Rabies Immune Globulin Distributors List Table 184. Rabies Immune Globulin Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Rabies Immune Globulin Image Figure 2. Global Rabies Immune Globulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Immune Globulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Rabies Immune Globulin Sales (2021-2032) & (K Units) Figure 5. ERIG Image Figure 6. Global ERIG Sales YoY Growth (2021-2032) & (K Units) Figure 7. HRIG Image Figure 8. Global HRIG Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Rabies Immune Globulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rabies Immune Globulin Market Share by Type 2025 VS 2032 Figure 11. North America Rabies Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Rabies Immune Globulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Rabies Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rabies Immune Globulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rabies Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rabies Immune Globulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rabies Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rabies Immune Globulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rabies Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rabies Immune Globulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rabies Immune Globulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Category II Exposure Image Figure 24. Global Category II Exposure Sales YoY Growth (2021-2032) & (K Units) Figure 25. Category III Exposure Image Figure 26. Global Category III Exposure Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Rabies Immune Globulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Rabies Immune Globulin Market Share by Application 2025 VS 2032 Figure 29. North America Rabies Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 30. North America Rabies Immune Globulin Sales Market Share in Value by Application in 2025 Figure 31. Europe Rabies Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Rabies Immune Globulin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Rabies Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Rabies Immune Globulin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Rabies Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Rabies Immune Globulin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Rabies Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Rabies Immune Globulin Sales Market Share in Value by Application in 2025 Figure 39. North America Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Rabies Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Rabies Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Rabies Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Rabies Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rabies Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Rabies Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Rabies Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rabies Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Rabies Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Rabies Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rabies Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Rabies Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Rabies Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Rabies Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rabies Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Rabies Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Rabies Immune Globulin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Rabies Immune Globulin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • ERIG
  • HRIG
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Sichuan Yuanda Shuyang
  • Weiguang Bio
  • Shanghai RAAS
  • Sanofi
  • Shuanglin Bio
  • VINS
  • Kamada
  • Grifols
  • CSL Behring
  • CNBG
  • CBPO
  • Bharat Serum

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rabies Immune Globulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rabies Immune Globulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rabies Immune Globulin Market by Type
  6. 1.3.1 ERIG
  7. 1.3.2 HRIG
  8. 1.4 Global Rabies Immune Globulin Market Size by Type
  9. 1.4.1 Global Rabies Immune Globulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rabies Immune Globulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rabies Immune Globulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rabies Immune Globulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rabies Immune Globulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rabies Immune Globulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rabies Immune Globulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rabies Immune Globulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rabies Immune Globulin Industry Trends
  2. 2.2 Rabies Immune Globulin Industry Drivers
  3. 2.3 Rabies Immune Globulin Industry Opportunities and Challenges
  4. 2.4 Rabies Immune Globulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rabies Immune Globulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Rabies Immune Globulin Sales (2021-2026)
  3. 3.3 Global Top Players by Rabies Immune Globulin Price (2021-2026)
  4. 3.4 Global Rabies Immune Globulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rabies Immune Globulin Major Company Production Sites & Headquarters
  6. 3.6 Global Rabies Immune Globulin Company, Product Type & Application
  7. 3.7 Global Rabies Immune Globulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rabies Immune Globulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rabies Immune Globulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rabies Immune Globulin Tier 1, Tier 2, and Tier 3
4 Rabies Immune Globulin Regional Status and Outlook
  1. 4.1 Global Rabies Immune Globulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rabies Immune Globulin Historic Market Size by Region
  3. 4.2.1 Global Rabies Immune Globulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rabies Immune Globulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rabies Immune Globulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rabies Immune Globulin Forecasted Market Size by Region
  7. 4.3.1 Global Rabies Immune Globulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rabies Immune Globulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rabies Immune Globulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rabies Immune Globulin by Application
  1. 5.1 Rabies Immune Globulin Market by Application
  2. 5.1.1 Category II Exposure
  3. 5.1.2 Category III Exposure
  4. 5.2 Global Rabies Immune Globulin Market Size by Application
  5. 5.2.1 Global Rabies Immune Globulin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Rabies Immune Globulin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Rabies Immune Globulin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Rabies Immune Globulin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Rabies Immune Globulin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Rabies Immune Globulin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Rabies Immune Globulin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Rabies Immune Globulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sichuan Yuanda Shuyang
  2. 6.1.1 Sichuan Yuanda Shuyang Company Information
  3. 6.1.2 Sichuan Yuanda Shuyang Business Overview
  4. 6.1.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio
  6. 6.1.5 Sichuan Yuanda Shuyang Recent Developments
  7. 6.2 Weiguang Bio
  8. 6.2.1 Weiguang Bio Company Information
  9. 6.2.2 Weiguang Bio Business Overview
  10. 6.2.3 Weiguang Bio Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Weiguang Bio Rabies Immune Globulin Product Portfolio
  12. 6.2.5 Weiguang Bio Recent Developments
  13. 6.3 Shanghai RAAS
  14. 6.3.1 Shanghai RAAS Company Information
  15. 6.3.2 Shanghai RAAS Business Overview
  16. 6.3.3 Shanghai RAAS Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS Rabies Immune Globulin Product Portfolio
  18. 6.3.5 Shanghai RAAS Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Rabies Immune Globulin Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Shuanglin Bio
  26. 6.5.1 Shuanglin Bio Company Information
  27. 6.5.2 Shuanglin Bio Business Overview
  28. 6.5.3 Shuanglin Bio Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shuanglin Bio Rabies Immune Globulin Product Portfolio
  30. 6.5.5 Shuanglin Bio Recent Developments
  31. 6.6 VINS
  32. 6.6.1 VINS Company Information
  33. 6.6.2 VINS Business Overview
  34. 6.6.3 VINS Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 VINS Rabies Immune Globulin Product Portfolio
  36. 6.6.5 VINS Recent Developments
  37. 6.7 Kamada
  38. 6.7.1 Kamada Company Information
  39. 6.7.2 Kamada Business Overview
  40. 6.7.3 Kamada Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kamada Rabies Immune Globulin Product Portfolio
  42. 6.7.5 Kamada Recent Developments
  43. 6.8 Grifols
  44. 6.8.1 Grifols Company Information
  45. 6.8.2 Grifols Business Overview
  46. 6.8.3 Grifols Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grifols Rabies Immune Globulin Product Portfolio
  48. 6.8.5 Grifols Recent Developments
  49. 6.9 CSL Behring
  50. 6.9.1 CSL Behring Company Information
  51. 6.9.2 CSL Behring Business Overview
  52. 6.9.3 CSL Behring Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CSL Behring Rabies Immune Globulin Product Portfolio
  54. 6.9.5 CSL Behring Recent Developments
  55. 6.10 CNBG
  56. 6.10.1 CNBG Company Information
  57. 6.10.2 CNBG Business Overview
  58. 6.10.3 CNBG Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CNBG Rabies Immune Globulin Product Portfolio
  60. 6.10.5 CNBG Recent Developments
  61. 6.11 CBPO
  62. 6.11.1 CBPO Company Information
  63. 6.11.2 CBPO Business Overview
  64. 6.11.3 CBPO Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CBPO Rabies Immune Globulin Product Portfolio
  66. 6.11.5 CBPO Recent Developments
  67. 6.12 Bharat Serum
  68. 6.12.1 Bharat Serum Company Information
  69. 6.12.2 Bharat Serum Business Overview
  70. 6.12.3 Bharat Serum Rabies Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bharat Serum Rabies Immune Globulin Product Portfolio
  72. 6.12.5 Bharat Serum Recent Developments
7 North America by Country
  1. 7.1 North America Rabies Immune Globulin Sales by Country
  2. 7.1.1 North America Rabies Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rabies Immune Globulin Sales by Country (2021-2026)
  4. 7.1.3 North America Rabies Immune Globulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rabies Immune Globulin Market Size by Country
  6. 7.2.1 North America Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rabies Immune Globulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Rabies Immune Globulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rabies Immune Globulin Sales by Country
  2. 8.1.1 Europe Rabies Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rabies Immune Globulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Rabies Immune Globulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rabies Immune Globulin Market Size by Country
  6. 8.2.1 Europe Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rabies Immune Globulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rabies Immune Globulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rabies Immune Globulin Sales by Country
  2. 9.1.1 Asia-Pacific Rabies Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rabies Immune Globulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rabies Immune Globulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rabies Immune Globulin Market Size by Country
  6. 9.2.1 Asia-Pacific Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rabies Immune Globulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rabies Immune Globulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rabies Immune Globulin Sales by Country
  2. 10.1.1 South America Rabies Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rabies Immune Globulin Sales by Country (2021-2026)
  4. 10.1.3 South America Rabies Immune Globulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rabies Immune Globulin Market Size by Country
  6. 10.2.1 South America Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rabies Immune Globulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Rabies Immune Globulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rabies Immune Globulin Sales by Country
  2. 11.1.1 Middle East and Africa Rabies Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rabies Immune Globulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rabies Immune Globulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rabies Immune Globulin Market Size by Country
  6. 11.2.1 Middle East and Africa Rabies Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rabies Immune Globulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rabies Immune Globulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rabies Immune Globulin Value Chain Analysis
  2. 12.1.1 Rabies Immune Globulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rabies Immune Globulin Production Mode & Process
  7. 12.2 Rabies Immune Globulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rabies Immune Globulin Distributors
  10. 12.2.3 Rabies Immune Globulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst